Business Services Industry
Cambridge, Mass.-Based Pharmaceutical Firm Expects Big Sales for Cancer Drug.
Knight Ridder/Tribune Business News, January, 2004
By Ross Kerber, The Boston Globe Knight Ridder/Tribune Business News
Jan. 13--Millennium Pharmaceuticals Inc. yesterday said it expects to sell up to $160 million worth of its Velcade cancer drug this year, nearly three times its 2003 sales, and said layoffs and restructuring moves made last year will help it reach profitability by 2006 before certain costs.
The Cambridge company also expects to surpass its previous guidance that it would have revenue of $420 million in 2003, a net loss of $535 million for the year, and a loss of $290 million excluding certain costs. Millennium made the announcements at a healthcare investor conference in San Francisco.
The company last year won approvals to use Velcade to treat multiple myeloma, a...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
Presented by the Premiere Rewards Gold Card from American Express